| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |